Vizionfocus, Inc.

Vizionfocus, Inc.

TTWSE:4771
206.50
TWD
-3.50
(-1.67%)
16.81EPS
12.89P/E
11.51BMarket Cap
Nov 06Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9.3
12.1
17.17
28.11
35.27
49.29
52.94
59.84
68.78
Basic EPS, GAAP
0.04
2.49
2.94
4.64
6.02
10.77
11.81
12.71
15.2
Free Cash Flow per Basic Share
-5.08
-7.52
-6.3
-1.02
8.95
-8.34
3.48
-2.37
-11.47
Dividend per Share
- -
- -
- -
- -
1.5
2.49
3.3
5.54
- -
Book Value per Share
7.54
16.39
19.46
27.38
31.5
34.07
60.99
68.08
70.54
Tangible Book Value per Share
7.32
16.06
19.06
26.93
30.44
32.53
59.04
65.35
67.71
Basic Weighted Avg Shares
34
48
50
51
52
52
57
58
59
Sales/Revenue/Turnover
315
585
855
1,420
1,834
2,572
3,002
3,487
4,031
Operating Margin (%)
-3.32
13.8
19.03
21.73
26.52
28.48
29.05
28.8
29.26
Depreciation Expense
42
80
138
169
234
279
355
409
443
Net Income, GAAP
1
120
146
234
313
562
670
741
891
Effective Tax Rate (%)
- -
- -
- -
15.65
17.01
21.42
20.79
19.96
20.95
Profit Margin (%)
0.43
20.57
17.12
16.49
17.06
21.86
22.3
21.24
22.11
Working Capital
185
427
616
864
1,026
803
1,621
1,614
1,104
LT Debt
- -
368
635
601
615
1,376
1,131
1,375
1,646
Total Equity
466
1,015
1,293
1,809
2,022
2,036
3,850
4,409
4,615
Return on Invested Capital (%)
- -
- -
- -
11.47
11.24
19.79
15.51
14.22
15.81
Return on Capital (%)
- -
- -
- -
8.56
11.89
14.79
14.15
12.43
13.96
Return on Common Equity (%)
- -
19.34
15.7
19.22
20.44
32.83
25.17
19.71
23.39

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
212
168
161
LT Borrowings
1,115
1,180
1,405
LT Finance Leases
260
252
241
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
59
59
59
Market Capitalization
10,125
10,597
11,512

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,658
2,662
2,725
Cash, Cash Equivalents & STI
1,289
1,181
1,085
Accounts Receivable, Net
880
938
1,065
Inventories
361
380
384
Total Current Liabilities
1,044
1,037
1,620
Payables & Accruals
- -
- -
- -
ST Debt
212
168
161
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
31.19%
14.52%
Free Cash Flow
- -
-318.91%
-169.84%
Net Income, GAAP
- -
40.6%
10.63%
Sales/Revenue/Turnover
- -
33.67%
16.17%
Total Cash Common Dividend
- -
- -
72.3%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
768
730
742
762
3,002
2025
811
872
854
951
3,487
2026
1,031
1,196
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3.42
3
2.5
2.92
11.81
2025
3.32
2.58
3.3
3.51
12.71
2026
3.66
4.73
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3.3
2025
- -
- -
- -
- -
5.54
2026
- -
- -
- -
- -
- -

Company Description

CEO
Angus Shih
Full Time Employees
486
Sector
Electronic technology
Industry
Electronic components
Address
No. 66, Youyi Road Miaoli TX Taiwan 35059
IPO Date
Mar 18, 2024
Business
Vizionfocus Inc. (4771.TW) manufactures and sells soft disposable contact lenses, including daily, bi-weekly, and monthly replacement types with 38% and 55% moisture content; the company offers spherical (myopia/hyperopia), toric, multifocal, color/tinted, blue light blocking, and silicone hydrogel lenses, such as performance-tinted multifocal (ocufilcon D), B12+HA, menthol-infused highly moist materials, and second-generation blue light blocking variants; it also provides research, design, development, and wholesale services for optical instruments and medical equipment. Founded in 2012 and headquartered in Zhunan Township, Miaoli County, Taiwan, Vizionfocus operates factories in Taiwan (Zhunan headquarters and second factory) and Jiangsu Danyang, China, with monthly production capacity exceeding 57 million pieces as of 2025; the company serves markets in Japan (54% of 2024 revenue), China (41%), the United States, Taiwan, Southeast Asia, and Europe through 55 product licenses and quality certifications including ISO 13485, CE MDD, Japan QMS, and China systems. Recent developments include the 2024 launch of toric, multifocal, and second-generation blue light blocking lenses; expansion of silicone hydrogel color lenses with DK/t 100 and surface hydrophilic treatment; new offerings in China such as SiHy series and 6-month replacement colored contacts; a resolved patent infringement lawsuit with Pegavision in September 2025; and plans for a new headquarters in Zhunan, Taiwan, in 2026 alongside capacity buildup and market share growth in differentiated products.